Literature DB >> 21452266

Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus.

Laura J Julian1, Chris Tonner, Ed Yelin, Jinoos Yazdany, Laura Trupin, Lindsey A Criswell, Patricia P Katz.   

Abstract

OBJECTIVE: Depression and cardiovascular disease are common and debilitating comorbidities associated with systemic lupus erythematosus (SLE). In this study, history of cardiovascular events, cardiovascular risk factors, and SLE disease-related factors were evaluated as longitudinal predictors of depression in a large cohort of patients with SLE.
METHODS: Data were derived from 663 adult participants in the 2004-2008 Lupus Outcomes Study, who were followed for up to 5 annual interviews. Multivariate logistic regression analyses using generalized estimating equations were used to determine predictors of the development of increased depressive symptom severity over a 12-month period (Center for Epidemiologic Studies Depression Scale [CES-D] score of 23 or greater), yielding 2,224 paired observations. Predictors included sociodemographics, traditional cardiovascular risk factors (reported presence of heart disease, history of stroke or myocardial infarction, hypertension, hypercholesterolemia, diabetes mellitus, obesity, smoking status, and family history), and SLE-specific risk factors (glucocorticoid use, renal involvement, disease duration, and disease activity).
RESULTS: The annual incidence of depression was 12% in this cohort. Multivariate predictors of new-onset depression included younger age (ages 20-39 years: odds ratio [OR] 2.3, 95% confidence interval [95% CI] 1.3-3.9; ages 40-59 years: OR 1.8, 95% CI 1.1-2.7), Hispanic/Latino ethnicity (OR 1.8, 95% CI 1.2-2.8), having some college education (OR 1.8, 95% CI 1.1-3.0), baseline CES-D score (OR per point 1.1, 95% CI 1.1-1.2), presence of diabetes mellitus (OR 1.8, 95% CI 1.1-2.8), and baseline SLE disease activity (OR 1.2, 95% CI 1.1-1.4).
CONCLUSION: These results suggest that, in addition to known sociodemographic factors, the presence of diabetes mellitus and SLE disease activity may play a role in the development of depression in SLE.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2011        PMID: 21452266      PMCID: PMC3713607          DOI: 10.1002/acr.20426

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  71 in total

1.  Activity loss and the onset of depressive symptoms: do some activities matter more than others?

Authors:  P P Katz; E H Yelin
Journal:  Arthritis Rheum       Date:  2001-05

2.  Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991.

Authors:  C M Vargas; V L Burt; R F Gillum; E R Pamuk
Journal:  Prev Med       Date:  1997 Sep-Oct       Impact factor: 4.018

3.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-10

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

Authors:  Sergio M A Toloza; América G Uribe; Gerald McGwin; Graciela S Alarcón; Barri J Fessler; Holly M Bastian; Luis M Vilá; Ruihua Wu; Yehuda Shoenfeld; Jeffrey M Roseman; John D Reveille
Journal:  Arthritis Rheum       Date:  2004-12

Review 6.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors: 
Journal:  Arthritis Rheum       Date:  1999-04

7.  Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease.

Authors:  E Kozora; L L Thompson; S G West; B L Kotzin
Journal:  Arthritis Rheum       Date:  1996-12

8.  The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus.

Authors:  H Ainiala; J Loukkola; J Peltola; M Korpela; A Hietaharju
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

9.  Psychosocial correlates of morbidity in women with systemic lupus erythematosus.

Authors:  M M Ward; D S Lotstein; T M Bush; R E Lambert; R van Vollenhoven; C M Neuwelt
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

10.  ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables.

Authors:  J G Hanly
Journal:  Lupus       Date:  2004       Impact factor: 2.911

View more
  19 in total

1.  Depression and Progression of Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus.

Authors:  April Jorge; Apinya Lertratanakul; Jungwha Lee; William Pearce; David McPherson; Trina Thompson; Emma Barinas-Mitchell; Rosalind Ramsey-Goldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-21       Impact factor: 4.794

2.  Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus.

Authors:  Edward Yelin; Chris Tonner; Laura Trupin; Stuart A Gansky; Laura Julian; Patricia Katz; Jinoos Yazdany; Rachel Kaiser; Lindsey A Criswell
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-02       Impact factor: 4.794

Review 3.  Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus.

Authors:  Anisha B Dua; Zahi Touma; Sergio Toloza; Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

4.  Prevalence and risk factors of anxiety and depression in patients with systemic lupus erythematosus in Southwest China.

Authors:  Xia Xie; Dongmei Wu; Hong Chen
Journal:  Rheumatol Int       Date:  2016-08-31       Impact factor: 2.631

5.  Alterations in Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus.

Authors:  J M Chi; M Mackay; A Hoang; K Cheng; C Aranow; J Ivanidze; B Volpe; B Diamond; P C Sanelli
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-21       Impact factor: 3.825

6.  Socioeconomic Predictors of Incident Depression in Systemic Lupus Erythematosus.

Authors:  Natalie Mccormick; Laura Trupin; Edward H Yelin; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-12-08       Impact factor: 4.794

7.  Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus.

Authors:  Sara G Murray; Jinoos Yazdany; Rachel Kaiser; Lindsey A Criswell; Laura Trupin; Edward H Yelin; Patricia P Katz; Laura J Julian
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-09       Impact factor: 4.794

8.  Depression Risk in Young Adults With Juvenile- and Adult-Onset Lupus: Twelve Years of Followup.

Authors:  Andrea M Knight; Laura Trupin; Patricia Katz; Edward Yelin; Erica F Lawson
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-03       Impact factor: 4.794

Review 9.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

10.  Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  Benchalak Maneeton; Narong Maneeton; Worawit Louthrenoo
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-05       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.